Talking Points

  • Autor: Vários
  • Narrador: Vários
  • Editor: Podcast
  • Duración: 26:34:46
  • Mas informaciones

Informações:

Sinopsis

A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.

Episodios

  • Episode 115: The GALACTIC-HF Trial

    07/04/2021 Duración: 14min

    John Teerlink and C. Michael Gibson discuss omecamtiv mecarbil in chronic HFrEF.

  • Episode 114: The NACMI COVID-19 Registry

    24/03/2021 Duración: 28min

    Timothy Henry and C. Michael Gibson discuss outcomes from the North American registry.

  • Episode 113: The EXPLORER-HCM Trial

    17/03/2021 Duración: 10min

    Iacopo Olivotto and C. Michael Gibson discuss mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy.

  • Episode 112: FLASH Registry: Acute Hemodynamic Improvement

    03/03/2021 Duración: 06min

    C. Michael Gibson and Catalin Toma discuss acute hemodynamic improvement with percutaneous mechanical thrombectomy in a real-world pulmonary embolism population.

  • Episode 111: The PARALLAX Trial

    17/02/2021 Duración: 09min

    Burkert Pieske and C. Michael Gibson discuss sacubitril/valsartan versus individualized RAAS blockade in HFpEF.

  • Episode 110: The HOME-PE Trial

    03/02/2021 Duración: 09min

    Pierre-Marie Roy and C. Michael Gibson discuss hospitalization or outpatient management of PE.

  • Episode 109: The EAST-AFNET 4 Trial

    20/01/2021 Duración: 14min

    Paulus Kirchhof and C. Michael Gibson discuss early rhythm control therapy in patients with atrial fibrillation.

  • Episode 108: The BPLTTC Trial

    06/01/2021 Duración: 05min

    Kazem Rahimi and C. Michael Gibson discuss BP-lowering for prevention of cardiovascular events.

  • Episode 107: LoDoCo2 Low-Dose Colchicine in Coronary Disease

    16/12/2020 Duración: 07min

    Dr. Jan Cornel and Dr. C. Michael Gibson Discuss: LoDoCo2 Low-Dose Colchicine in Coronary Disease.

  • Episode 106: TCT Connect 2020

    02/12/2020 Duración: 28min

    C. Michael Gibson, Ajay Kirtane, Mamas Mamas, and Roxana Mehran talk TCT 2020.

  • Episode 105: POPULAR TAVI

    04/11/2020 Duración: 06min

    C. Michael Gibson and Jorn Brouwer discuss aspirin with or without clopidogrel after transcatheter aortic valve replacement.

  • Episode 104: EMPEROR Reduced

    21/10/2020 Duración: 16min

    C. Michael GIbson and Milton Packer Discuss empagliflozin in heart failure with reduced ejection fraction.

  • Episode 103: New ESC NSTEMI Guidelines

    07/10/2020 Duración: 09min

    C. Michael Gibson and Roxana Mehran discuss new ESC NSTEMI guidelines and more

  • Episode 102: Innovation in Mitral Valve Repair

    02/09/2020 Duración: 02min

    C. Michael Gibson and Steven Goldberg discuss REDUCE-FMR and sham-controlled trials in MV repair.

  • Episode 101: PARTNER 2A: 5-Year Outcomes

    19/08/2020 Duración: 02min

    C. Michael Gibson and Vinod Thourani discuss 5-year outcomes in this randomized trial of TAVR vs SAVR in intermediate-risk patients.

  • Episode 100: COAPT Cost-effectiveness Analysis Plus Health-Status Outcomes in PARTNER 3

    05/08/2020 Duración: 05min

    Suzanne Baron and C. Michael Gibson discuss important new details from these two structural heart disease trials.

  • Episode 99: EVOLVE Short DAPT: 3-Month DAPT in Patients

    22/07/2020 Duración: 02min

    C. Michael Gibson and Ajay Kirtane review the results of this single-arm stent study.

  • Episode 98: #WomenAs1: The Battle for Gender Equality

    15/07/2020 Duración: 06min

    Roxana Mehran brings C. Michael Gibson up to speed on a campaign to promote talent in medicine by offering professional opportunities to female physicians.

  • Episode 97: TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin

    02/07/2020 Duración: 04min

    Usman Baber, who led this thrombogenicity substudy, walks C. Michael Gibson through the key findings.

  • Episode 96: IVUS-XPL: Intravascular Ultrasound-Guided vs. Angiography-Guided PCI

    17/06/2020 Duración: 05min

    C. Michael Gibson and Myeong-Ki Hong discuss 5-year outcomes in this randomized trial.

página 7 de 10